Clinical Trial Update: Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia [Phase 3]

View source ↗

Summary

A pilot, randomized, double-blind study comparing oseltamivir to placebo for immune thrombocytopenia in a Phase 3 setting; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• OSELTAMIVIR (oseltamivir phosphate)

Snippet

Sponsor: Unity Health Toronto | Conditions: Immune Thrombocytopenia | Phase 3 | Status: UNKNOWN